Literature DB >> 23146950

The special programme of research in human reproduction: forty years of activities to achieve reproductive health for all.

Giuseppe Benagiano1, Catherine d'Arcangues, Jennifer Harris Requejo, Alessandra Schafer, Lale Say, Mario Merialdi.   

Abstract

The Special Programme of Research in Human Reproduction (HRP), co-sponsored by the UNDP, UNFPA, WHO, and the World Bank, is celebrating 40 years of activities with an expansion of its mandate and new co-sponsors. When it began, in 1972, the main focus was on evaluating the acceptability, effectiveness, and safety of existing fertility-regulating methods, as well as developing new, improved modalities for family planning. In 1994, HRP not only made major contributions to the Plan of Action of the International Conference on Population and Development (ICPD); it also broadened its scope of work to include other aspects of health dealing with sexuality and reproduction, adding a specific perspective on gender issues and human rights. In 2002, HRP's mandate was once again broadened to include sexually transmitted infections and HIV/AIDS and in 2003 it was further expanded to research activities on preventing violence against women and its many dire health consequences. Today, the work of the Programme includes research on: the sexual and reproductive health of adolescents, women, and men; maternal and perinatal health; reproductive tract and sexually transmitted infections (including HIV/AIDS); family planning; infertility; unsafe abortion; sexual health; screening for cancer of the cervix in developing countries, and gender and reproductive rights. Additional activities by the Programme have included: fostering international cooperation in the field of human reproduction; the elaboration of WHO's first Global Reproductive Health Strategy; work leading to the inclusion of ICPD's goal 'reproductive health for all by 2015' into the Millennium Development Goal framework; the promotion of critical interagency statements on the public health, legal, and human rights implications of female genital mutilation and gender-biased sex selection. Finally, HRP has been involved in the creation of guidelines and tools, such as the 'Medical eligibility criteria for contraceptive use', the 'Global handbook for family planning providers', the 'Definition of core competencies in primary health care', and designing tools for operationalizing a human rights approach to sexual and reproductive health programmes.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23146950     DOI: 10.1159/000343067

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  5 in total

1.  The World Health Organization's safe abortion guidance document.

Authors:  Paul F A Van Look; Jane Cottingham
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

2.  Levonorgestrel butanoate intramuscular injection does not reliably suppress ovulation for 90 days in obese and normal-BMI women: a pilot study.

Authors:  Alison B Edelman; Ganesh Cherala; Hong Li; Francis Pau; Diana L Blithe; Jeffrey T Jensen
Journal:  Contraception       Date:  2016-07-27       Impact factor: 3.375

Review 3.  Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment.

Authors:  B Meczekalski; A Czyzyk; M Kunicki; A Podfigurna-Stopa; L Plociennik; G Jakiel; M Maciejewska-Jeske; K Lukaszuk
Journal:  J Endocrinol Invest       Date:  2016-06-14       Impact factor: 4.256

4.  Esters of levonorgestrel and etonogestrel intended as single, subcutaneous-injection, long-lasting contraceptives.

Authors:  Frederick A Meece; Gulzar Ahmed; Hareesh Nair; Bindu Santhamma; Rajeshwar R Tekmal; Chumang Zhao; Nicole E Pollok; Julia Lara; Ze'ev Shaked; Klaus Nickisch
Journal:  Steroids       Date:  2018-08-04       Impact factor: 2.668

5.  Motherhood and decision-making among women living with HIV in developed countries: a systematic review with qualitative research synthesis.

Authors:  Ariadna Huertas-Zurriaga; Patrick A Palmieri; Joan E Edwards; Sandra K Cesario; Sergio Alonso-Fernandez; Lidia Pardell-Dominguez; Karen A Dominguez-Cancino; Juan M Leyva-Moral
Journal:  Reprod Health       Date:  2021-07-10       Impact factor: 3.223

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.